stockportfolio.pro
Vertex Pharmaceuticals Incorporated Net Income 2008–2025
Vertex Pharmaceuticals Incorporated (VRTX) annual net income by fiscal year, computed from SEC filings.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $3.95B | 32.9% | +838.1% |
| FY 2024 | $-535.60M | -4.9% | -114.8% |
| FY 2023 | $3.62B | 36.7% | +9.0% |
| FY 2022 | $3.32B | 37.2% | +41.8% |
| FY 2021 | $2.34B | 30.9% | -13.6% |
| FY 2020 | $2.71B | 43.7% | +130.4% |
| FY 2019 | $1.18B | 28.3% | -43.9% |
| FY 2018 | $2.10B | 68.8% | +695.8% |
| FY 2017 | $263.48M | 10.6% | +335.1% |
| FY 2016 | $-112.05M | -6.6% | +79.9% |
| FY 2015 | $-556.33M | -53.9% | +24.7% |
| FY 2014 | $-738.55M | -127.2% | -66.0% |
| FY 2013 | $-445.03M | -36.7% | -315.8% |
| FY 2012 | $-107.03M | -7.0% | -461.9% |
| FY 2011 | $29.57M | 2.1% | +103.9% |
| FY 2010 | $-754.63M | -526.3% | -17.5% |
| FY 2009 | $-642.18M | -630.3% | -39.6% |
| FY 2008 | $-459.85M | -262.0% | — |
Source: Vertex Pharmaceuticals Incorporated SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Vertex Pharmaceuticals Incorporated
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeVertex Pharmaceuticals Incorporated — frequently asked questions
What is Vertex Pharmaceuticals Incorporated's net income?
Vertex Pharmaceuticals Incorporated (VRTX) reported net income of $3.95B for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Vertex Pharmaceuticals Incorporated's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.